Compare GSK plc (GSK) vs Quanta Services Inc (PWR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Quanta Services Inc — how do they compare? GSK plc trades at $52.58 (market cap $101.34B), while Quanta Services Inc trades at $635.13 (market cap $97.37B). The key difference: GSK plc and Quanta Services Inc are close in size by market cap, and GSK plc pays the higher dividend (3.49%). Which is the better fit depends on your goals.
| GSK | PWR | |
|---|---|---|
Market Cap | $101.34B | $97.37B |
Sector | Health | Industrials |
52-Week High | $61.18 | $785.24 |
52-Week Low | $36.20 | $372.50 |
Enterprise Value | $121.95B | $103.32B |
Dividend Yield | 3.49% | 0.07% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK's stock trades at $51.25, down 1.99% on the day, with a bearish technical signal from moving averages. Fundamentally, the company shows strong profitability with a 17.78% net margin and 36.42% ROE, supported by a consistent earnings beat history. Recent positive clinical trial results for Jemperli in rectal cancer and FDA approval for Utebzi highlight pipeline progress. Valuation appears reasonable with a P/E of 13.71 and EV/EBITDA of 9.16.
The outlook balances a solid core business and promising oncology pipeline against a mixed analyst consensus and near-term cash flow pressures. Key opportunities lie in execution of new drug launches and the upcoming CEO strategy update, while risks include clinical trial setbacks, competitive pressures, and integration of potential acquisitions like Nuvalent.
Quanta Services (PWR) trades at $660.94, up 2.2% on the day, with a neutral technical signal and strong fundamental growth. Revenue has grown from $17.1B in 2022 to $28.5B in 2025, with net income reaching $1.03B. The stock carries a premium valuation with a P/E of 89, supported by a 75% analyst buy rating and a consensus price target of $836.80. Recent news highlights the company's positioning to benefit from AI-driven infrastructure spending and a record $48B backlog.
The outlook for PWR is positive, driven by robust infrastructure demand and strategic alignment with AI and grid modernization trends. Key risks include execution challenges from aggressive capital expenditure and sensitivity to economic cycles. The stock's premium valuation leaves little room for error, but strong earnings beats and institutional support suggest continued upside potential if growth targets are met.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Quanta Services Inc
Quanta Services is a leading provider of specialty contracting services, delivering comprehensive infrastructure solutions for the electric and gas utility, communications, pipeline, and energy industries in the United States, Canada, and Australia. Quanta reports its results under two reportable segments: electric power infrastructure solutions and underground utility and infrastructure solutions. In October 2021, the company completed the acquisition of Blattner, a provider of comprehensive engineering, procurement, and construction solutions to customers in the renewable energy industry.
Read more on PWR →
